BioGend Therapeutics Co., Ltd. (TPEX:6733)
Taiwan · Delayed Price · Currency is TWD 28.30
-0.70 (-2.41%)
May 8, 2026, 1:30 PM CST
BioGend Therapeutics Market Cap
BioGend Therapeutics has a market cap or net worth of 3.52 billion as of May 8, 2026. Its market cap has increased by 10.85% in one year.
Market Cap
3.52B
Enterprise Value
2.68B
Revenue
229.81M
Ranking
n/a
PE Ratio
n/a
Stock Price
28.30
Market Cap Chart
Since June 18, 2019, BioGend Therapeutics's market cap has increased from 2.71B to 3.52B, an increase of 29.66%. That is a compound annual growth rate of 3.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 3.52B | -26.30% |
| Dec 31, 2025 | 4.78B | 14.21% |
| Dec 31, 2024 | 4.18B | -11.18% |
| Dec 29, 2023 | 4.71B | 109.50% |
| Dec 30, 2022 | 2.25B | -18.50% |
| Dec 30, 2021 | 2.76B | -22.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Formosa Pharmaceuticals | 4.06B |
| Sinew Pharma | 3.90B |
| Sagittarius Life Science | 3.81B |
| Energenesis Biomedical CO.,LTD. | 3.61B |
| Shine-On BioMedical | 3.21B |
| SYN-TECH Chem. & Pharm. | 3.21B |
| Genovate Biotechnology | 3.09B |
| TWi Biotechnology | 3.03B |